Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

The need for an alternative method to determine intravascular volumes.

Lobigs LM, Peeling P, Dawson B, Schumacher YO.

Eur J Sport Sci. 2018 Jun 17:1-9. doi: 10.1080/17461391.2018.1484175. [Epub ahead of print]

PMID:
29911484
2.

Application of the Athlete's Performance Passport for Doping Control: A Case Report.

Iljukov S, Bermon S, Schumacher YO.

Front Physiol. 2018 Mar 29;9:280. doi: 10.3389/fphys.2018.00280. eCollection 2018.

3.

Athlete Performance Monitoring in Anti-Doping.

Hopker J, Schumacher YO, Fedoruk M, Mørkeberg J, Bermon S, Iljukov S, Aikin R, Sottas PE.

Front Physiol. 2018 Mar 23;9:232. doi: 10.3389/fphys.2018.00232. eCollection 2018. No abstract available.

4.

Validation of a blood marker for plasma volume in endurance athletes during a live-high train-low altitude training camp.

Lobigs LM, Garvican-Lewis LA, Vuong VL, Tee N, Gore CJ, Peeling P, Dawson B, Schumacher YO.

Drug Test Anal. 2018 Feb 19. doi: 10.1002/dta.2370. [Epub ahead of print]

PMID:
29457371
5.

Performance Profiling-Perspectives for Anti-doping and beyond.

Iljukov S, Schumacher YO.

Front Physiol. 2017 Dec 22;8:1102. doi: 10.3389/fphys.2017.01102. eCollection 2017.

6.

The athlete's hematological response to hypoxia: A meta-analysis on the influence of altitude exposure on key biomarkers of erythropoiesis.

Lobigs LM, Sharpe K, Garvican-Lewis LA, Gore CJ, Peeling P, Dawson B, Schumacher YO.

Am J Hematol. 2018 Jan;93(1):74-83. doi: 10.1002/ajh.24941. Epub 2017 Oct 31.

PMID:
29027252
7.

Influence of combined iron supplementation and simulated hypoxia on the haematological module of the athlete biological passport.

Garvican-Lewis LA, Vuong VL, Govus AD, Schumacher YO, Hughes D, Lovell G, Eichner D, Gore CJ.

Drug Test Anal. 2018 Apr;10(4):731-741. doi: 10.1002/dta.2303. Epub 2017 Nov 16.

PMID:
28929623
8.

The Athlete Biological Passport: How to Personalize Anti-Doping Testing across an Athlete's Career?

Robinson N, Sottas PE, Schumacher YO.

Med Sport Sci. 2017;62:107-118. doi: 10.1159/000460722. Epub 2017 Jun 2.

PMID:
28578329
9.

A step towards removing plasma volume variance from the Athlete's Biological Passport: The use of biomarkers to describe vascular volumes from a simple blood test.

Lobigs LM, Sottas PE, Bourdon PC, Nikolovski Z, El-Gingo M, Varamenti E, Peeling P, Dawson B, Schumacher YO.

Drug Test Anal. 2018 Feb;10(2):294-300. doi: 10.1002/dta.2219. Epub 2017 Jul 27.

PMID:
28548390
10.

The use of biomarkers to describe plasma-, red cell-, and blood volume from a simple blood test.

Lobigs LM, Sottas PE, Bourdon PC, Nikolovski Z, El-Gingo M, Varamenti E, Peeling P, Dawson B, Schumacher YO.

Am J Hematol. 2017 Jan;92(1):62-67. doi: 10.1002/ajh.24577.

11.

The effect of cumulative endurance exercise on leptin and adiponectin and their role as markers to monitor training load.

Voss SC, Nikolovski Z, Bourdon PC, Alsayrafi M, Schumacher YO.

Biol Sport. 2016 Mar;33(1):23-8. doi: 10.5604/20831862.1180173. Epub 2015 Nov 19.

12.

Can I tell you something? I'm doping….

Dijkstra HP, van Dyk N, Schumacher YO.

Br J Sports Med. 2016 May;50(9):510-1. doi: 10.1136/bjsports-2015-095602. Epub 2015 Dec 29. No abstract available.

PMID:
26714757
13.

Impact of Altitude on Power Output during Cycling Stage Racing.

Garvican-Lewis LA, Clark B, Martin DT, Schumacher YO, McDonald W, Stephens B, Ma F, Thompson KG, Gore CJ, Menaspà P.

PLoS One. 2015 Dec 2;10(12):e0143028. doi: 10.1371/journal.pone.0143028. eCollection 2015.

14.

Iron deficiency in sports - definition, influence on performance and therapy.

Clénin G, Cordes M, Huber A, Schumacher YO, Noack P, Scales J, Kriemler S.

Swiss Med Wkly. 2015 Oct 29;145:w14196. doi: 10.4414/smw.2015.14196. eCollection 2015. Review.

15.

Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth.

Schumacher Y, Aparicio T, Ourabah S, Baraille F, Martin A, Wind P, Dentin R, Postic C, Guilmeau S.

Oncogene. 2016 May 19;35(20):2602-14. doi: 10.1038/onc.2015.283. Epub 2015 Aug 24.

PMID:
26300003
16.

Within-subject haemoglobin variation in elite athletes: a longitudinal investigation of 13 887 haemoglobin concentration readings.

Lobigs LM, Knight EJ, Schumacher YO, Gore CJ.

Drug Test Anal. 2016 Feb;8(2):228-34. doi: 10.1002/dta.1809. Epub 2015 May 19.

PMID:
25990883
17.

Influence of transport and time on blood variables commonly measured for the athlete biological passport.

Robinson N, Giraud S, Schumacher YO, Saugy M.

Drug Test Anal. 2016 Feb;8(2):199-207. doi: 10.1002/dta.1804. Epub 2015 Apr 29.

PMID:
25924812
18.

The athlete biological passport: haematology in sports.

Schumacher YO.

Lancet Haematol. 2014 Oct;1(1):e8-e10. doi: 10.1016/S2352-3026(14)70009-2. Epub 2014 Sep 30. No abstract available.

PMID:
27030069
19.

High altitude, prolonged exercise, and the athlete biological passport.

Schumacher YO, Garvican LA, Christian R, Lobigs LM, Qi J, Fan R, He Y, Wang H, Gore CJ, Ma F.

Drug Test Anal. 2015 Jan;7(1):48-55. doi: 10.1002/dta.1717. Epub 2014 Sep 24.

PMID:
25252093
20.

Stage racing at altitude induces hemodilution despite an increase in hemoglobin mass.

Garvican-Lewis LA, Schumacher YO, Clark SA, Christian R, Menaspà P, Plowman J, Stephens B, Qi J, Fan R, He Y, Martin DT, Thompson KG, Gore CJ, Ma F.

J Appl Physiol (1985). 2014 Sep 1;117(5):463-72. doi: 10.1152/japplphysiol.00242.2014. Epub 2014 Jul 3.

21.

A fast automated screening method for the detection of blood transfusion in sports.

Leuenberger N, Ansermet C, Pottgiesser T, Baume N, Robinson N, Saugy M, Schumacher YO.

Drug Test Anal. 2014 Nov-Dec;6(11-12):1141-3. doi: 10.1002/dta.1676. Epub 2014 May 22.

PMID:
24853344
22.

The effect of a period of intense exercise on the marker approach to detect growth hormone doping in sports.

Voss SC, Robinson N, Alsayrafi M, Bourdon PC, Schumacher YO, Saugy M, Giraud S.

Drug Test Anal. 2014 Jun;6(6):582-6. doi: 10.1002/dta.1666. Epub 2014 May 14.

PMID:
24827554
23.

Application of the optimized CO-rebreathing method for determination of hemoglobin mass in patients with polycythemia vera.

Ahlgrim C, Schumacher YO, Wrobel N, Waller CF, Pottgiesser T.

Ann Hematol. 2014 Jul;93(7):1159-65. doi: 10.1007/s00277-014-2020-5. Epub 2014 Feb 1.

PMID:
24488226
24.

Position statement--altitude training for improving team-sport players' performance: current knowledge and unresolved issues.

Girard O, Amann M, Aughey R, Billaut F, Bishop DJ, Bourdon P, Buchheit M, Chapman R, D'Hooghe M, Garvican-Lewis LA, Gore CJ, Millet GP, Roach GD, Sargent C, Saunders PU, Schmidt W, Schumacher YO.

Br J Sports Med. 2013 Dec;47 Suppl 1:i8-16. doi: 10.1136/bjsports-2013-093109.

25.

Altitude training and haemoglobin mass from the optimised carbon monoxide rebreathing method determined by a meta-analysis.

Gore CJ, Sharpe K, Garvican-Lewis LA, Saunders PU, Humberstone CE, Robertson EY, Wachsmuth NB, Clark SA, McLean BD, Friedmann-Bette B, Neya M, Pottgiesser T, Schumacher YO, Schmidt WF.

Br J Sports Med. 2013 Dec;47 Suppl 1:i31-9. doi: 10.1136/bjsports-2013-092840. Review.

26.

Current strategies of blood doping detection.

Pottgiesser T, Schumacher YO.

Anal Bioanal Chem. 2013 Dec;405(30):9625-39. doi: 10.1007/s00216-013-7270-x. Epub 2013 Aug 10. Review.

PMID:
23934350
27.

Variability of serum markers of erythropoiesis during 6 days of racing in highly trained cyclists.

Voss SC, Alsayrafi M, Bourdon PC, Klodt F, Nonis D, Hopkins WG, Schumacher YO.

Int J Sports Med. 2014 Feb;35(2):89-94. doi: 10.1055/s-0033-1345177. Epub 2013 Jul 18.

PMID:
23868682
28.

Circulating microRNAs as biomarkers for detection of autologous blood transfusion.

Leuenberger N, Schumacher YO, Pradervand S, Sander T, Saugy M, Pottgiesser T.

PLoS One. 2013 Jun 20;8(6):e66309. doi: 10.1371/journal.pone.0066309. Print 2013.

29.

Ethical considerations for experiments involving elite athletes and "doping".

Schumacher YO, Garvican LA, Pottgiesser T, Martin DT, Ahlgrim C, Gore CJ.

J Appl Physiol (1985). 2013 May 15;114(10):1362. doi: 10.1152/japplphysiol.01477.2012. No abstract available.

30.

The effect of a period of intensive exercise on the isoform test to detect growth hormone doping in sports.

Voss SC, Giraud S, Alsayrafi M, Bourdon PC, Schumacher YO, Saugy M, Robinson N.

Growth Horm IGF Res. 2013 Aug;23(4):105-8. doi: 10.1016/j.ghir.2013.03.006. Epub 2013 Apr 19.

PMID:
23608056
31.

Flow cytometric assessment of erythrocyte shape through analysis of FSC histograms: use of kurtosis and implications for longitudinal evaluation.

Ahlgrim C, Pottgiesser T, Sander T, Schumacher YO, Baumstark MW.

PLoS One. 2013;8(3):e59862. doi: 10.1371/journal.pone.0059862. Epub 2013 Mar 21.

32.

Longitudinal observation of Epstein-Barr virus antibodies in athletes during a competitive season.

Pottgiesser T, Schumacher YO, Wolfarth B, Schmidt-Trucksäss A, Bauer G.

J Med Virol. 2012 Sep;84(9):1415-22. doi: 10.1002/jmv.23253.

PMID:
22825820
33.

The impact of long-haul air travel on variables of the athlete's biological passport.

Schumacher YO, Klodt F, Nonis D, Pottgiesser T, Alsayrafi M, Bourdon PC, Voss SC.

Int J Lab Hematol. 2012 Dec;34(6):641-7. doi: 10.1111/j.1751-553X.2012.01450.x. Epub 2012 Jul 16.

PMID:
22805050
34.

Biomarker monitoring in sports doping control.

Pottgiesser T, Schumacher YO.

Bioanalysis. 2012 Jun;4(10):1245-53. doi: 10.4155/bio.12.101. Review.

PMID:
22651568
35.

Scientific expertise and the Athlete Biological Passport: 3 years of experience.

Schumacher YO, d'Onofrio G.

Clin Chem. 2012 Jun;58(6):979-85. doi: 10.1373/clinchem.2012.183061. Epub 2012 Apr 4.

36.

Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.

Schumacher YO, Saugy M, Pottgiesser T, Robinson N.

Drug Test Anal. 2012 Nov;4(11):846-53. doi: 10.1002/dta.406. Epub 2012 Feb 28. Review.

PMID:
22374784
37.

Hypogonadism and anemia in an athlete.

Korsten-Reck U, Seufert J, Dickhuth HH, Schumacher YO, König D.

Int J Sports Med. 2012 Feb;33(2):154-6. doi: 10.1055/s-0031-1285927. Epub 2011 Nov 17.

PMID:
22095327
38.

Hemoglobin mass and biological passport for the detection of autologous blood doping.

Pottgiesser T, Echteler T, Sottas PE, Umhau M, Schumacher YO.

Med Sci Sports Exerc. 2012 May;44(5):835-43. doi: 10.1249/MSS.0b013e31823bcfb6.

PMID:
21988933
39.

Short-term hematological effects upon completion of a four-week simulated altitude camp.

Pottgiesser T, Garvican LA, Martin DT, Featonby JM, Gore CJ, Schumacher YO.

Int J Sports Physiol Perform. 2012 Mar;7(1):79-83. Epub 2011 Aug 30.

PMID:
21941010
40.

Changes in blood lactate concentrations during different treadmill exercise test protocols.

Prettin S, Roecker K, Ruehl S, Deibert P, Schumacher YO, Hirschmüller A, Dickhuth HH.

J Sports Med Phys Fitness. 2011 Jun;51(2):179-84.

PMID:
21681150
41.

Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.

Pottgiesser T, Sottas PE, Echteler T, Robinson N, Umhau M, Schumacher YO.

Transfusion. 2011 Aug;51(8):1707-15. doi: 10.1111/j.1537-2995.2011.03076.x. Epub 2011 Mar 7.

PMID:
21382045
42.

An attempt to quantify the placebo effect from a three-week simulated altitude training camp in elite race walkers.

Saunders PU, Ahlgrim C, Vallance B, Green DJ, Robertson EY, Clark SA, Schumacher YO, Gore CJ.

Int J Sports Physiol Perform. 2010 Dec;5(4):521-34.

PMID:
21266736
43.

Comment on ‘"The hybrid algorithm (Hbmr) to fight against blood doping in sports"’ by F. Sanchis-Gomar et al.

Schumacher YO, Pottgiesser T.

Scand J Med Sci Sports. 2010 Dec;20(6):791. doi: 10.1111/j.1600-0838.2010.01231.x. No abstract available.

PMID:
21182671
44.

The contribution of haemoglobin mass to increases in cycling performance induced by simulated LHTL.

Garvican LA, Pottgiesser T, Martin DT, Schumacher YO, Barras M, Gore CJ.

Eur J Appl Physiol. 2011 Jun;111(6):1089-101. doi: 10.1007/s00421-010-1732-z. Epub 2010 Nov 27.

PMID:
21113616
45.

The impact of acute gastroenteritis on haematological markers used for the athletes biological passport - report of 5 cases.

Schumacher YO, Pottgiesser T.

Int J Sports Med. 2011 Feb;32(2):147-50. doi: 10.1055/s-0030-1268463. Epub 2010 Nov 25.

PMID:
21110289
46.

Physiology, power output, and racing strategy of a Race Across America finisher.

Schumacher YO, Ahlgrim C, Prettin S, Pottgiesser T.

Med Sci Sports Exerc. 2011 May;43(5):885-9. doi: 10.1249/MSS.0b013e3181fec009.

PMID:
20962691
47.

Reticulocytes in athletes: Longitudinal aspects and the influence of long- and short-term exercise.

Schumacher YO, Sahm D, Baumstark MW, Pottgiesser T.

Drug Test Anal. 2010 Oct;2(10):469-74. doi: 10.1002/dta.180.

PMID:
20886465
48.

Stability and robustness of blood variables in an antidoping context.

Robinson N, Sottas PE, Pottgiesser T, Schumacher YO, Saugy M.

Int J Lab Hematol. 2011 Apr;33(2):146-53. doi: 10.1111/j.1751-553X.2010.01256.x. Epub 2010 Aug 16.

PMID:
20718874
49.

Are 10 min of seating enough to guarantee stable haemoglobin and haematocrit readings for the athlete's biological passport?

Ahlgrim C, Pottgiesser T, Robinson N, Sottas PE, Ruecker G, Schumacher YO.

Int J Lab Hematol. 2010 Oct;32(5):506-11. doi: 10.1111/j.1751-553X.2009.01213.x. Epub 2010 Feb 9.

PMID:
20148988
50.

Diurnal and exercise-related variability of haemoglobin and reticulocytes in athletes.

Schumacher YO, Wenning M, Robinson N, Sottas PE, Ruecker G, Pottgiesser T.

Int J Sports Med. 2010 Apr;31(4):225-30. doi: 10.1055/s-0029-1243617. Epub 2010 Feb 10.

PMID:
20148373

Supplemental Content

Loading ...
Support Center